Innoviva SG&A Expense (TTM) Trends | YCharts

Innoviva, Inc. (INVA)

21.33 -0.02 (-0.09%) USD | NASDAQ | Sep 04, 16:00

21.31 -0.02 (-0.09%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for INVA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2004. Start Trial.

Date	Value
June 30, 2026	126.42M
March 31, 2026	118.26M
December 31, 2025	113.32M
September 30, 2025	112.52M
June 30, 2025	111.45M
March 31, 2025	112.78M
December 31, 2024	115.69M
September 30, 2024	110.68M
June 30, 2024	113.10M
March 31, 2024	108.90M
December 31, 2023	98.23M
September 30, 2023	89.37M
June 30, 2023	88.54M
March 31, 2023	76.78M
December 31, 2022	63.54M
September 30, 2022	49.20M
June 30, 2022	24.25M
March 31, 2022	16.69M
December 31, 2021	16.19M
September 30, 2021	18.54M
June 30, 2021	18.94M
March 31, 2021	17.31M
December 31, 2020	13.88M
September 30, 2020	10.74M
June 30, 2020	12.45M

Date	Value
March 31, 2020	14.20M
December 31, 2019	14.66M
September 30, 2019	14.96M
June 30, 2019	14.02M
March 31, 2019	14.08M
December 31, 2018	22.75M
September 30, 2018	22.88M
June 30, 2018	27.18M
March 31, 2018	33.15M
December 31, 2017	32.26M
September 30, 2017	35.10M
June 30, 2017	31.89M
March 31, 2017	27.73M
December 31, 2016	23.19M
September 30, 2016	17.58M
June 30, 2016	17.06M
March 31, 2016	15.74M
December 31, 2015	14.93M
September 30, 2015	21.30M
June 30, 2015	25.35M
March 31, 2015	29.05M
December 31, 2014	46.44M
September 30, 2014	56.54M
June 30, 2014	60.19M
March 31, 2014	62.96M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Zevra Therapeutics, Inc.	74.63M
Collegium Pharmaceutical, Inc.	327.69M
CorMedix, Inc.	138.00M
ANI Pharmaceuticals, Inc.	324.76M
Corcept Therapeutics, Inc.	556.47M